471 related articles for article (PubMed ID: 30342280)
21. Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis.
Qu N; Zhang L; Ji QH; Chen JY; Zhu YX; Cao YM; Shen Q
World J Surg; 2015 Oct; 39(10):2459-70. PubMed ID: 26099728
[TBL] [Abstract][Full Text] [Related]
22. Predictive Factors of Central-Compartment Lymph Node Metastasis for Clinical N0 Papillary Thyroid Carcinoma With Strap Muscle Invasion.
Xue S; Zhang L; Pang R; Wang P; Jin M; Guo L; Zhou Y; Dong B; Chen G
Front Endocrinol (Lausanne); 2020; 11():511. PubMed ID: 33013682
[No Abstract] [Full Text] [Related]
23. Risk factors for central lymph node metastasis in papillary thyroid carcinoma: A National Cancer Data Base (NCDB) study.
Suman P; Wang CH; Abadin SS; Moo-Young TA; Prinz RA; Winchester DJ
Surgery; 2016 Jan; 159(1):31-9. PubMed ID: 26435436
[TBL] [Abstract][Full Text] [Related]
24. Lateral lymph node metastasis in papillary thyroid cancer: Is there a difference between PTC and PTMC?
Ma W; Guo Y; Hua T; Li L; Lv T; Wang J
Medicine (Baltimore); 2024 Apr; 103(17):e37734. PubMed ID: 38669400
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections.
Li M; Zhu XY; Lv J; Lu K; Shen MP; Xu ZL; Wu ZS
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3801-3807. PubMed ID: 28975988
[TBL] [Abstract][Full Text] [Related]
26. Risk factors of central lymph node metastasis in cN0 papillary thyroid carcinoma: a study of 529 patients.
Liang K; He L; Dong W; Zhang H
Med Sci Monit; 2014 May; 20():807-11. PubMed ID: 24831428
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X
Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112
[TBL] [Abstract][Full Text] [Related]
28. Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.
Seong CY; Chai YJ; Lee SM; Kim SJ; Choi JY; Lee KE; Hwang KT; Park SW; Yi KH
PLoS One; 2018; 13(7):e0200166. PubMed ID: 30016353
[TBL] [Abstract][Full Text] [Related]
29. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.
Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK
World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552
[TBL] [Abstract][Full Text] [Related]
30. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.
Roh JL; Kim JM; Park CI
Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of central lymph node dissection for papillary thyroid carcinoma in cN0 T1/T2].
Zhao SY; Ma YH; Yin Z; Zhan XX; Cheng RC; Qian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):105-109. PubMed ID: 29429179
[No Abstract] [Full Text] [Related]
32. Surgical Extent of Central Lymph Node Dissection for Papillary Thyroid Carcinoma Located in the Isthmus: A Propensity Scoring Matched Study.
Shuai Y; Yue K; Duan Y; Zhou M; Fang Y; Liu J; Liu D; Jing C; Wu Y; Wang X
Front Endocrinol (Lausanne); 2021; 12():620147. PubMed ID: 34211434
[TBL] [Abstract][Full Text] [Related]
33. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
34. Surgical extent of central lymph node dissection in clinically node-negative papillary thyroid cancer.
Kim WW; Park HY; Jung JH
Head Neck; 2013 Nov; 35(11):1616-20. PubMed ID: 23322499
[TBL] [Abstract][Full Text] [Related]
35. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.
Hu D; Lin H; Zeng X; Wang T; Deng J; Su X
World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139
[TBL] [Abstract][Full Text] [Related]
36. Machine learning algorithms for identifying contralateral central lymph node metastasis in unilateral cN0 papillary thyroid cancer.
Ren A; Zhu J; Wu Z; Ming J; Ruan S; Xu M; Huang T
Front Endocrinol (Lausanne); 2024; 15():1385324. PubMed ID: 38800481
[TBL] [Abstract][Full Text] [Related]
37. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma.
Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M
Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230
[TBL] [Abstract][Full Text] [Related]
38. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of ipsilateral central lymph node metastasis for contralateral central lymph node metastasis in patients with thyroid cancer: Systematic review and meta-analysis.
Kim DH; Kim GJ; Kim SW; Hwang SH
Head Neck; 2021 Oct; 43(10):3177-3184. PubMed ID: 34124791
[TBL] [Abstract][Full Text] [Related]
40. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]